Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

The review of the questionnaire about the effectiveness of Sumatriptane (CROSBI ID 546337)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Strahinja, Višnja ; Willheim, Ksenija ; Šepić Grahovac, Dubravka The review of the questionnaire about the effectiveness of Sumatriptane // Abstracts. Beč: International Pharmaceutical Federation (FIP), 2000. str. 100-x

Podaci o odgovornosti

Strahinja, Višnja ; Willheim, Ksenija ; Šepić Grahovac, Dubravka

engleski

The review of the questionnaire about the effectiveness of Sumatriptane

We wanted to evaluate the effectiveness of sumatriptane by analysing the questionnaire filled by patients suffering from migraine. The questionnaire consisted of four questions: which dosage of sumatriptane do you use in migraine attacks? How would you evaluate the effectiveness of this dosage of sumatriptane? Account all other drugs you used before in treating migraine attacks? How would you evaluate the effectiveness of those drugs in comparison to sumatriptane? We analysed 97 questionnaires and found: 47% of patients used 50 mg sumatriptane, 43% used 100 mg, and 10% used 200 mg sumatriptane. The dosage is excellent in 68%, good in 28% and inefficient in 10 patients. Before sumatriptane 64% used dihydroergotamine, 28% caffetine, 10% Aspirine and 10% noraminophenasone. 89% said sumatriptane is more efficient, 4% thought that the efficiency is the same, and 7% evaluated lesser effectiveness.The questionnaire showed that 50, 100 mg of sumatriptane is enough for a desired effect, 90% of patients evaluated excellent or good efficiency of sumatriptane, 89% as a far more efficient. We should have more analogue questionnaires for drugs which are on the market more than five years to get better feedback.

Migraine; Sumatriptane

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

100-x.

2000.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Abstracts

Beč: International Pharmaceutical Federation (FIP)

Podaci o skupu

Pharmacy World Congress 2000

poster

26.08.2000-31.08.2000

Beč, Austrija

Povezanost rada

Farmacija